🔎 Trials Near Me

Hjem › Akut lymfoblastisk leukemi › Illinois › Chicago

Kliniske studier for Akut lymfoblastisk leukemi i Chicago, IL

19 studier for Akut lymfoblastisk leukemi søker deltakere på steder i og rundt Chicago (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Mount Sinai Hospital Medical Center, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • og 1 flere
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

RekruttererFase 1/2
  • The University of Chicago Medical Center, Chicago
30 Days · Alle kjønn · Oppdatert 16. sep. 2026 · NCT04065399

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RekruttererFase 1/2
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Opp til 22 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

RekruttererFase 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Alder 7 til 25 · Alle kjønn · Oppdatert 19. aug. 2026 · NCT05082519

A Study of CTD402 in T-ALL/LBL Patients

RekruttererFase 1/2
  • University of Chicago, Chicago
Alder 1 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT07070219

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

RekruttererObservasjonsstudie
  • The University of Chicago, Chicago
1 Day – 17 Years · Alle kjønn · Oppdatert 14. aug. 2026 · NCT06274788

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

RekruttererFase 1/2
  • Research Site, Chicago
Alder 12 og eldre · Alle kjønn · Oppdatert 13. jul. 2026 · NCT07109219

Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

Rekrutterer
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
Alder 15 og eldre · Alle kjønn · Oppdatert 10. jul. 2026 · NCT06446661

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekruttererObservasjonsstudie
  • Northwestern Memorial Hospital, Chicago
  • Rush University Medical Center, Chicago
  • University of Illinois at Chicago, Chicago
  • og 2 flere
Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

Rekrutterer
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
Alder 14 og eldre · Alle kjønn · Oppdatert 30. jun. 2026 · NCT03932903

Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

RekruttererFase 1
  • University of Chicago Medical Center, Chicago
Alder 18 til 39 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT03571321

Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)

RekruttererFase 2
  • University of Chicago Medical Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 5. jun. 2026 · NCT04747912

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

RekruttererObservasjonsstudie
  • Lurie Children's Hospital-Chicago, Chicago
Alle aldre · Alle kjønn · Oppdatert 18. mai 2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

RekruttererFase 1
  • University of Chicago, Chicago
Alder 13 og eldre · Alle kjønn · Oppdatert 5. mai 2026 · NCT04771572

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

RekruttererFase 1/2
  • Northwestern, Chicago
Alder 12 og eldre · Alle kjønn · Oppdatert 24. mar. 2026 · NCT04988555

A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

RekruttererFase 1/2
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 18. mar. 2026 · NCT06207123

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

RekruttererFase 2
  • University of Chicago Comprehensive Cancer Center, Chicago
Alder 18 til 54 · Alle kjønn · Oppdatert 17. mar. 2026 · NCT06918431

Venetoclax Basket Trial for High Risk Hematologic Malignancies

RekruttererFase 1
  • Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Alder 1 til 40 · Alle kjønn · Oppdatert 12. mar. 2026 · NCT05292664

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RekruttererFase 1
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Alder 1 til 21 · Alle kjønn · Oppdatert 6. des. 2024 · NCT05476770

Akut lymfoblastisk leukemi-studier i andre byer

Andre studier i Chicago

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.